Chenghai Li
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Genetics 5
- Mesenchymal stem cell research 5
-
- Lung Cancer Treatments and Mutations 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Bin Wang (4 shared papers)Hua Zhao (3 shared papers)Guolin Zou (1 shared paper)Sihong Wang (1 shared paper)Jing Chen (1 shared paper)Yang Chen (1 shared paper)Ping Wang (1 shared paper)Wenjuan Wu (1 shared paper)
- Journals
- Infectious Diseases and Therapy (1 paper)Pharmacological Research (1 paper)Translational Oncology (1 paper)Journal of Biomechanical Engineering (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenghai Li
13 papers receiving 305 citations
Peers
Comparison fields: 5 of 71
- Genetics 107
- Urology 13
- Biomaterials 26
- Molecular Biology 120
- Rheumatology 23
Countries citing papers authored by Chenghai Li
This map shows the geographic impact of Chenghai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghai Li more than expected).
Fields of papers citing papers by Chenghai Li
This network shows the impact of papers produced by Chenghai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghai Li. The network helps show where Chenghai Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenghai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 113 | |
| 2 | 2015 | 63 | |
| 3 | 2020 | 44 | |
| 4 | 2014 | 23 | |
| 5 | 2020 | 15 | |
| 6 | 2018 | 10 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 6 | |
| 11 | 2022 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2016 | 0 |
About Chenghai Li
Chenghai Li is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Oncology, having authored 14 papers that have together received 306 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Lung Cancer Treatments and Mutations (3 papers), Pancreatic function and diabetes (1 paper), MicroRNA in disease regulation (1 paper), Diabetes Management and Research (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Genetics (107 citations), Urology (13 citations), Biomaterials (26 citations), Molecular Biology (120 citations) and Rheumatology (23 citations). Chenghai Li has collaborated with scholars based in China and United States. Frequent co-authors include Bin Wang, Hua Zhao, Guolin Zou, Sihong Wang, Jing Chen, Yang Chen, Ping Wang, Wenjuan Wu, Sihong Wang and Ningbo Liu. Their work appears in journals such as Infectious Diseases and Therapy, Pharmacological Research, Translational Oncology, Journal of Biomechanical Engineering and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.